Showing results (391-400 of 2,902) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|February 20, 2010
Potent antitumor effects of combined therapy with a telomerase-specific, replication-competent adenovirus (OBP-301) and IL-2 in a mouse model of renal cell carcinomaP Huang, H Kaku, J Chen, et al.Cancer Gene Therapy|February 9, 2010
Adenoviral targeting of gene expression to tumorsR T Hogg, J A Garcia, R D GerardCancer Gene Therapy|June 3, 2017
New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticlesM A Zaimy, N Saffarzadeh, A Mohammadi, et al.Cancer Gene Therapy|October 17, 2009
Imaging and therapy of experimental schwannomas using HSV amplicon vector-encoding apoptotic protein under Schwann cell promoterS Prabhakar, G J Brenner, B Sung, et al.Cancer Gene Therapy|May 15, 2018
Genomic landscape and prognostic analysis of mantle cell lymphomaPing Yang, Weilong Zhang, Jing Wang, et al.Cancer Gene Therapy|June 30, 2018
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapyFilippo Rossignoli, Giulia Grisendi, Carlotta Spano, et al.Cancer Gene Therapy|July 5, 2018
Complex consisting of antisense DNA and β-glucan promotes internalization into cell through Dectin-1 and hybridizes with target mRNA in cytosolNobuaki Fujiwara, Hiroto Izumi, Yasuo Morimoto, et al.Cancer Gene Therapy|January 16, 2010
Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical modelsJ Rousseau, V Escriou, P Perrot, et al.Cancer Gene Therapy|September 22, 2016
Mesenchymal stem cell: a new horizon in cancer gene therapyM Mohammadi, M R Jaafari, H R Mirzaei, et al.Cancer Gene Therapy|May 13, 2017
Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E in castration-resistant prostate cancer patientsK Fujita, Y Nakai, A Kawashima, et al.Pageof 291